Navigation Links
Houston Northwest Medical Center Recognized in the Top 15% of the Nation for Maternity Care Services from HealthGrades
Date:6/30/2009

HOUSTON, June 30 /PRNewswire/ -- Houston Northwest Medical Center announced today that HealthGrades, an independent healthcare ratings company, recognized them among the top 15% of hospitals for Maternity Care services as a recipient of a 5-Star Rating for 2009/2010. Houston Northwest Medical Center is one of only 218 hospitals nation-wide to be named a recipient of this prestigious distinction. HealthGrades found that wide gaps continue to persist in quality outcomes for maternity care and the best-performing hospitals had far fewer complications compared with poor-performing hospitals.

The Sixth Annual HealthGrades Women's Health in American Hospitals study found that best-performing hospitals had 52% fewer maternal complications among women who had vaginal births at their facility compared to poor-performing hospitals. In addition, among women who had either C-sections or Patient-choice C-sections at these top performing hospitals, they experienced 76% and 84% fewer complications respectively.

"To be ranked among the top 15 percent in the nation for maternity care is a great honor and is a tribute to our physicians and staff who deliver quality care to our patients year after year," said Becky Winders, women's services nursing director at Houston Northwest Medical Center.

Study findings include the following:

  • If all hospitals, among the 19 states studied, performed at the level of the best-performing hospitals from 2005 through 2007, 182,129 women may have avoided developing one or more in-hospital major obstetrics complications.
  • Best-performing hospitals had a 56% lower weight-stratified neonatal mortality compared to poor-performing hospitals.
  • C-section rates average approximately 32% among the 19 states studied.
  • Quality inconsistencies are seen when comparing states; those with the lowest complication rate
    '/>"/>

SOURCE Houston Northwest Medical Center
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
2. Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston
3. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
4. Houston Northwest Medical Centers Patient Outcomes Superior
5. Cohen Design Centers Sponsor the AIDS Walks in Los Angeles, Houston, Fort Lauderdale and New York
6. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
7. Houston Employers Hear New Research That Supports the Case for Retail Clinics
8. New St. Lukes Medical Clinic Selects Award-Winning globalcentara Provider(SM) by Houstons Global Healthcare Alliance
9. Houston Heart Surgeon Elected Vice President of Guatemala
10. University of Houstons Achenbaum wins GSAs 2007 Donald P. Kent Award
11. Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Space sensors shed new light on air quality 2Health News:Space sensors shed new light on air quality 3Health News:China Medical Technologies to Announce Financial Results for the Second Quarter Ended September 30, 2007 on November 20, 2007 2Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 2Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 3Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 4Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 5Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 6Health News:SAIC to Collaborate with UK Biometrics Institute 2Health News:SAIC to Collaborate with UK Biometrics Institute 3Health News:Spending more for lung cancer treatment did not substantially increase patients' lives 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 3
Breaking Medicine Technology:Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 2Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 3Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2LFAGW to Run Could I Have Lupus 3F Workshop on July 26 3B Mystics Game Follows 51830 1LFAGW to Run Could I Have Lupus 3F Workshop on July 26 3B Mystics Game Follows 51830 2LFAGW to Run Could I Have Lupus 3F Workshop on July 26 3B Mystics Game Follows 51830 3ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results 51826 1ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results 51826 2New Data Say Uninsured Account for Nearly One Fifth of Emergency Room Visits 51823 1New Data Say Uninsured Account for Nearly One Fifth of Emergency Room Visits 51823 2New Data Say Uninsured Account for Nearly One Fifth of Emergency Room Visits 51823 3